Published by The Economist, the article explores the emerging field of mitochondrial transplants, in which healthy mitochondria—the energy-producing organelles of cells—are transferred into damaged or dysfunctional cells to restore their function. Mitochondria perform many critical roles beyond energy production, including regulating cell death, signaling, and metabolism, so their dysfunction contributes to numerous diseases, from congenital conditions like Pearson’s syndrome to diabetes, cardiovascular disease, and neurological damage.

Researchers such as James McCully, Melanie Walker, and others are testing techniques in premature babies, stroke patients, and animal models. Early results suggest transplanted mitochondria can improve cell survival, reduce inflammation, and even rejuvenate aged cells. Trials are exploring applications for heart, lung, kidney, neuronal injuries, anemia, and rare mitochondrial disorders. The work raises the possibility that mitochondrial transplants could become a new therapeutic approach, potentially extending healthspan and combating a wide range of diseases.